Detalhe da pesquisa
1.
Tissue-specific genotype-phenotype correlations among USH2A-related disorders in the RUSH2A study.
Hum Mutat
; 43(5): 613-624, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35266249
2.
Auditory and olfactory findings in patients with USH2A-related retinal degeneration-Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A).
Am J Med Genet A
; 185(12): 3717-3727, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331386
3.
Visual Acuity Change over 12 Months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: ProgStar Report Number 6.
Ophthalmology
; 124(11): 1640-1651, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28549516
4.
Functional Vision in Patients With Biallelic USH2A Variants.
Am J Ophthalmol
; 260: 200-211, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135239
5.
Overcoming the Challenges to Clinical Development of X-Linked Retinitis Pigmentosa Therapies: Proceedings of an Expert Panel.
Transl Vis Sci Technol
; 12(6): 5, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294701
6.
Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 Years.
Am J Ophthalmol
; 250: 103-110, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36764426
7.
The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene.
Invest Ophthalmol Vis Sci
; 63(3): 17, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35293952
8.
Baseline Microperimetry and OCT in the RUSH2A Study: Structure-Function Association and Correlation With Disease Severity.
Am J Ophthalmol
; 244: 98-116, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36007554
9.
Tackling the Challenges of Product Development Through a Collaborative Rare Disease Network: The Foundation Fighting Blindness Consortium.
Transl Vis Sci Technol
; 10(4): 23, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34004001
10.
The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline.
Transl Vis Sci Technol
; 9(11): 9, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33133772
11.
Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity.
Am J Ophthalmol
; 219: 87-100, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32446738
12.
Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration.
J Ocul Pharmacol Ther
; 34(10): 700-709, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30412448
13.
Visual Acuity Change Over 24 Months and Its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease: ProgStar Study Report No. 10.
JAMA Ophthalmol
; 136(8): 920-928, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29902293
14.
Progression of Visual Acuity and Fundus Autofluorescence in Recent-Onset Stargardt Disease: ProgStar Study Report #4.
Ophthalmol Retina
; 1(6): 514-523, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-31047445
15.
Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension.
J Ocul Pharmacol Ther
; 21(4): 337-48, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16117698
16.
Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension.
Surv Ophthalmol
; 49 Suppl 1: S45-52, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15016561
17.
Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients.
J Cataract Refract Surg
; 30(8): 1653-60, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15313287
18.
Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases.
Invest Ophthalmol Vis Sci
; 58(9): 3456-3463, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28702674